The phrase "a proprietary formulation" is correct and usable in written English.
It can be used when referring to a unique or specially developed mixture or recipe that is owned by a company or individual.
Example: "The company has developed a proprietary formulation that enhances the effectiveness of their product."
Alternatives: "a unique blend" or "a patented mixture".
A proprietary formulation was chosen to undergo this suitability determination.
The particles are in what Dr. Baker described as a "proprietary formulation of mayonnaise" based on soybean oil.
We studied a novel pancreatic enzyme product, ALTU-135, a proprietary formulation of microbially derived lipase, protease, and amylase, to determine its efficacy and safety in treatment of pancreatic insufficiency (PI) in patients with cystic fibrosis (CF).
The new trial was supported by Abbott Laboratories and compared Abbott's Niaspan, a proprietary formulation of niacin, to Zetia in heart patients.
Saka's Sparkling Brut Rosé and still Rosé wines are blended with a proprietary formulation of tasteless, odorless water-soluble ratio of THC and CBD, derived from organic craft cannabis.
The company stimulates microbes with a "proprietary formulation of nutrients," in already-drilled natural gas wells, which enables the wells to produce more methane, the primary component of natural gas.
Premise of the study: This study presents Visikol™, a new proprietary formulation that can be used as an efficient replacement for chloral hydrate as a clearing agent for microscopic examination.
The aim of this study was to clinically evaluate a topical proprietary formulation containing lipophilic catechins (AverTeaX, Camellix, LLC, Evans, GA, USA) on recurrent herpes labialis.
Medium M3 is a defined proprietary formulation optimized for the growth of neuroendocrine cells (InCell Corp., San Antonio, TX, USA).
Without a consistent proprietary formulation and sound pharmacokinetic data, of the kind now reported routinely for new pharmaceutical products, there may be little value in further clinical trials.
11 ATX-101, the subject of this study, is an injectable proprietary formulation of synthetically derived deoxycholic acid (DCA), which disrupts adipocyte membranes leading to irreversible cell breakdown (adipocytolysis).
